Maria Bottazzi A Covid-19 vaccine from a lab out of Baylor University’s National School of Tropical Medicine arose from efforts that stemmed from the...
Breaking Down The 2800-Page, $1.5 Trillion Omnibus Bill 2022 The Omnibus Bill 2022 (Continuing Appropriations Act) is 2,800 pages long and...
Stockman: How The C-Suite Embraced Lockdowns And Economic War Authored by David Stockman via The Brownstone Institute, A while back, corporate...
The underlying science that made COVID-19 vaccines possible is the product of decades of painstaking research, well described in A Shot to Save the World. The...
The Oxford Nanopore Technologies share price has dropped 5.5% today after the gene-sequencing specialist… The post Oxford Nanopore share price down 5.5%...
URBANA, Ill. – Scientists at the University of Illinois at Urbana-Champaign and Mie University in Japan have developed monoclonal antibodies that prevent...
Just one dose of a new nanoparticle-based COVID-19 vaccine was enough to produce an immune response in animals on track with vaccines currently in clinical...
Maybe Spider-Man was on to something. Although spider silk and synthetic forms have been used for a wide range of applications – including bullet-proof...
Scientists from Nanyang Technological University, Singapore (NTU Singapore) have developed a novel method of delivering drugs into human cells using large...
In a world-first, the DNA of a vulnerable species, the iconic Arabian Oryx, has been decoded. An international team led by the University of Sydney undertook...
Could health care stocks be the top picks in the stock market this week? The post Good Stocks To Buy Right Now? 4 Health Care Stocks...
AUGUSTA, Ga. (March 15, 2022) – Up to 80% of individuals who’ve had COVID-19 report temporary or lasting changes in their sense of taste, and scientists...
For the fourth time in as many weeks, a company focused on portable drug manufacturing is making noise. This time, Nutcracker Therapeutics has brought...
Tuberculosis is the second most common cause of death worldwide by an infectious pathogen, COVID-19 being the first. However, many aspects of TB’s long...
This article will examine what nanotechnology is, what it's used for and the three best nanotechnology stocks to buy now. The post Best Nanotechnology...
To celebrate International Women’s Day, we speak to design engineer at Envair Technology Darina Shopova; managing director, UK The post IWD: Spotlight...
A UK-based CDMO has landed a supply agreement with Versameb to provide its doggybone DNA for the company’s pipeline, including for its lead candidate...
Scientists pinpointed 16 new genetic variants in people who developed severe COVID-19 in a large study published on March 7 that could help researchers...
The pharmaceutical industry is still picking its way through the debris of the pandemic but the gloom can The post Switch on to The Age of...
Pfizer's COVID-19 Vaccine Goes Into Liver Cells And Is Converted To DNA: Study Authored by Meiling Lee via The Epoch Times (emphasis ours), The...
Will There Be A 2024 Presidential Election? Authored by Jim Quinn via The Burning Platform blog, “All tyrannies rule through fraud and...
CRISPR startups and large pharmaceutical companies are combining their respective strengths to accelerate the development of CRISPR treatments. Relationships...
The outlook for oral COVID medication officially went mainstream on Tuesday. At his State of the Union speech, President Joe Biden said his administration...
Whitehead: "These Are Dangerous Times For America And The World" Authored by John W. Whitehead & Nisha Whitehead via The Rutherford Institute, “Never...
The varying impurity profiles of mRNA from the IVT step calls on options in purification technologies that would allow process development scientists to...
Seattle-based A-Alpha Bio will support research into new therapies for COVID-19 variants in a collaboration with Lawrence Livermore National Laboratory....
Chestnut Hill, Mass. (2/25/2022) – The unique properties of the atom-thick sheet of carbon, known as graphene, enabled a new penny-sized, multiplexed...
Tillman Gerngross As market volatility sweeps through the landscape, CEO changes are really ramping up, and topping the list is Tillman Gerngross, a force...
With several critical trials on deck this year, is now the time to invest in the advanced technology by investing in gene editing stocks? The post...
Sponsored content brought to you by RNA therapeutics comprise a rapidly expanding category of drugs that will speed clinical solutions, actualize personalized...